MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0080753
Bibi Oncology Services Private Limited - healthcare in Thiruvananthapuram, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.14 Cr
▲ 56% YoY
Net loss · FY 2025
₹1.95 Cr
Net margin -21.3%
EBITDA · FY 2025
-₹35.6 Lakh
EBITDA margin -3.9%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹14.35 Cr
Issued & subscribed
Open charges
₹2.3 Cr
Satisfied ₹10.4 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
38
Provident fund records
About Bibi Oncology Services Private Limited
Data last updated:
Bibi Oncology Services Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India, a subsidiary of Haragovind Enterprises Private Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 26 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74900KL2015PTC047520. Its GSTIN is 36AAGCB2556H1ZP (Telangana).
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹14.35 Cr. It was formerly known as Bibi Healthcare Private Limited and Bibi Cancer Care Private Limited. It is led by directors including Nisar Alam Syed and Syed Tashreefullah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Pb No.1 Poonthi Road Anamugham Kumarapuram Anayara P O, Thiruvananthapuram, Kerala, India – 695029.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.14 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net loss of ₹1.95 Cr (net margin -21.3%) and EBITDA of -₹35.6 Lakh (EBITDA margin -3.9%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 3% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.3 Cr and satisfied charges of ₹10.4 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹2.99 Cr; the latest was in September 2016. Its 7 peer companies in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities) are compared by revenue, 3 larger and 4 smaller; the largest is Bangalore Institute of Gastroenterology Private Limited with revenue of ₹9.22 Cr.
Bibi Oncology Services Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0080753). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kimsglobal.com.
Company details
CIN U74900KL2015PTC047520
Registration Number 047520
Incorporation Date 26 March 2015
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Haragovind Enterprises Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0080753
Name history
Bibi Oncology Services has undergone 5 name changes throughout its history. The current legal name is Bibi Oncology Services Private Limited.
| Company Name | Status |
|---|---|
| Bibi Oncology Services Private Limited | Current |
| Bibi Healthcare Private Limited | Previous |
| Bibi Cancer Care Private Limited | Previous |
| Kims Bibi Healthcare Private Limited | Previous |
| Bibi Hospitals Private Limited | Previous |
CIN history
Bibi Oncology Services has one previous CIN (Corporate Identification Number): U74900TG2015PTC098172. The current CIN is U74900KL2015PTC047520, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900KL2015PTC047520 | Current |
| U74900TG2015PTC098172 | Previous |
Recognitions & Rankings of Bibi Oncology Services
Contact details
Bibi Oncology Services Private Limited's registered office is in Thiruvananthapuram, Kerala. Its website is kimsglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPb No.1 Poonthi Road Anamugham Kumarapuram Anayara P O, Thiruvananthapuram, Kerala, India – 695029
- IndustryHealthcare, Hospitals
To see the full contact details of Bibi Oncology Services Private Limited, buy the company report.
Comprehensive company report
Bibi Oncology Services Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bibi Oncology Services is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Bibi Oncology Services Private Limited, buy the company report.
Financials of Bibi Oncology Services Private Limited
FY 2024 filings availableBibi Oncology Services Private Limited reported revenue of ₹9.14 Cr (up 56% YoY) for FY 2025.
Revenue · FY 2025
₹9.14 Cr ▲ 56%
Net loss · FY 2025
₹1.95 Cr margin -21.3%
EBITDA · FY 2025
-₹35.6 Lakh margin -3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 7%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 69%
3 years · compounded
▼ 46%
5 years · compounded
▼ 19%
Revenue rose 56% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹35.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.95 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.9% | ||||
| Net Profit Margin | -21.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bibi Oncology Services Private Limited, buy the company report.
Board of directors of Bibi Oncology Services Private Limited
Bibi Oncology Services has 4 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisar Alam Syed | Director | 26 Mar 2015 | 11 Years 6 Months | Current |
| Syed Tashreefullah | Director | 23 May 2024 | 2 Years 5 Months | Current |
| Imran Syed | Director | 24 Jun 2024 | 2 Years 4 Months | Current |
| Khatija Syed | Director | 04 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Bibi Oncology Services Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bangalore Institute of Gastroenterology Private Limited | ₹9.22 Cr (FY 2025) | 163.0% | Bangalore, Karnataka, India | |||
| Dibru Garh Physiotheraphy Clinic Pvt Ltd | ₹9.2 Cr (FY 2025) | 55.0% | Assam, India | |||
| Shri Dwarkadhish Lifecare Private Limited | ₹9.15 Cr (FY 2025) | 52.0% | Gwalior, Madhya Pradesh, India | |||
| Bibi Oncology Services Private Limitedthis company | ₹9.14 Cr (FY 2025) | -₹1.95 Cr | -21.3% | 56.0% | 38 | Thiruvananthapuram, Kerala, India |
| Divine Super Speciality Hospital Private Limited | ₹9.09 Cr (FY 2024) | 450.0% | Ranchi, Jharkhand, India | |||
| Dr.Thiru Neuro & Multispeciality Hospital Private Limited | ₹9.08 Cr (FY 2024) | 8.0% | Salem, Tamil Nadu, India | |||
| Shivam Multispecialty and Accident Care Centre Private Limited | ₹9.07 Cr (FY 2021) | 36.0% | Pune, Maharashtra, India | |||
| KRS Nulife Hospitals Private Limited | ₹9.07 Cr (FY 2025) | 79.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Bibi Oncology Services Private Limited, buy the company report.
Auditor
Bibi Oncology Services Private Limited is audited by Rajesh Lakshman and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajesh Lakshman and Associates | FY 2023 | 08225S |
Shareholding
The shareholding of Bibi Oncology Services Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bibi Oncology Services Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.3 Cr
Satisfied charges
₹10.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jul 2016 | 100044474 | Hdfc Bank Limited | ₹2.3 Cr | Open | |
| 16 Feb 2018 | 100160828 | Hdfc Bank Limited | ₹2 Cr | Satisfied | |
| 05 Feb 2016 | 10626151 | Hdfc Bank Limited | ₹8.4 Cr | Satisfied |
To see the full charge records of Bibi Oncology Services Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Bibi Oncology Services Private Limited has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹2.99 Cr; the latest was in September 2016.
Total deals
3
Funding rounds
2
Acquisition
1
Disclosed funding
₹2.99 Cr
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Acquisition | ₹10.32 Cr | Buyer: Kims Cancer Care and Research Center Private Limited Seller: Kims Cancer Care and Research Center Private Limited |
| Jul 2015 | Funding round | ₹2.99 Cr | Investors: 3 individuals |
To see the full deal history of Bibi Oncology Services Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bibi Oncology Services Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by M/S. Nipoon Services, Rep. by Its Managing Partner E. Veeresham | Pending |
To see the full case history of Bibi Oncology Services Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bibi Oncology Services Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bibi Oncology Services Private Limited has a workforce of 38 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
38
Active EPFO establishments
1
Employee growth
-28.3%
GST
Bibi Oncology Services has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCB2556H1ZP | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bibi Oncology Services Private Limited, buy the company report.
Recent activity
Bibi Oncology Services Private Limited has 21 board changes on record since 2015: 4 appointments and 17 cessations. The latest: Syed Tashreefullah ceased to be Additional Director on 29 Sep 2024.
AGM
Bibi Oncology Services Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Syed Tashreefullah ceased to be Additional Director.
Appointed
Imran Syed was appointed as Director.
Charges
A charge registered on 16 Feb 2018 via Charge ID 100160828 with Hdfc Bank Limited was fully satisfied on 18 Jun 2024.
Charges
A charge registered on 05 Feb 2016 via Charge ID 10626151 with Hdfc Bank Limited was fully satisfied on 18 Jun 2024.
Appointed
Syed Tashreefullah was appointed as Director.
Filing
Bibi Oncology Services Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Ceased
Viqar Syed ceased to be Director.
Ceased
Faiz Bano ceased to be Additional Director.
Ceased
Syed Nusrath Farees ceased to be Additional Director.
Ceased
Imran Syed ceased to be Director.
Appointed
Khatija Syed was appointed as Director.
18 earlier events are in the company report.
Frequently asked questions
Bibi Oncology Services is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in hospitals, within the healthcare industry. It was incorporated on 26 March 2015 (11+ years old) and is registered under CIN U74900KL2015PTC047520.
Bibi Oncology Services has 4 current directors:
- Nisar Alam Syed - Director
- Syed Tashreefullah - Director
- Imran Syed - Director
- Khatija Syed - Director
The latest financial statements of Bibi Oncology Services on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bibi Oncology Services is 36AAGCB2556H1ZP, registered in Telangana.
The CIN (Corporate Identification Number) of Bibi Oncology Services is U74900KL2015PTC047520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bibi Oncology Services has 1 court case on record: 1 filed against it. 1 is pending.
Bibi Oncology Services was incorporated on 26 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ernakulam.
Bibi Oncology Services has 3 deals on record (2 funding rounds, 1 acquisition), with disclosed funding of ₹2.99 Cr; the latest was in September 2016.
The peers of Bibi Oncology Services by revenue are Bangalore Institute of Gastroenterology Private Limited, Dibru Garh Physiotheraphy Clinic Pvt Ltd, Shri Dwarkadhish Lifecare Private Limited, Divine Super Speciality Hospital Private Limited, Dr.Thiru Neuro & Multispeciality Hospital Private Limited and 2 more, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities).
Syed Tashreefullah ceased to be Additional Director on 29 Sep 2024. Imran Syed was appointed as Director on 24 Jun 2024. Syed Tashreefullah was appointed as Director on 23 May 2024. Bibi Oncology Services has 21 board changes on record in total.
Yes, Bibi Oncology Services is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0080753).